Crossmark

Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations

Crossref DOI link: https://doi.org/10.1016/j.aohep.2020.05.007

Published Print: 2021-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Delgado Martínez, Carolina

Gómez-Rubio, Mariano

Gómez-Domínguez, Cecilia
License Information

Text and Data Mining valid from 2021-03-01

Version of Record valid from 2020-07-13
More Information

This article is maintained by: Elsevier

Article Title: Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2020.05.007

Content Type: article

Copyright: © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below